Ken Griffin Atri Cure, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$20.34 - $29.5 $12,204 - $17,700	-600 Reduced 4.76%	12,000 $336,000
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $55,608 - $81,452	2,800 Added 28.57%	12,600 $286,000
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $42,315 - $56,670	-1,500 Reduced 13.27%	9,800 $298,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $366,189 - $480,075	11,100 Added 5550.0%	11,300 $403,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $53,456 - $75,049	-1,300 Reduced 86.67%	200 $8,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $24,264 - $29,760	600 Added 66.67%	1,500 $74,000
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $14,347 - $18,888	400 Added 80.0%	900 $37,000
Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $234,359 - $332,150	-7,000 Reduced 93.33%	500 $22,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $87,975 - $121,026	2,300 Added 44.23%	7,500 $293,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.72B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.